ANSSI, announced that beginning in 2027 it will stop certifying security products that do not include quantum-resistant ...

"It is rare to see the kind of blatant and repeated misconduct that Sabatini [acting as plaintifs' lawyer] has committed in this case." ...

Insilico Medicine and China Medical System Holdings announced on July 12, 2026, a second AI-driven drug discovery collaboration in fewer than three months, with the specific brain-disease target ...

AI drug discovery moves into the factory: Insilico Medicine and Bora Pharmaceuticals launched a strategic alliance on July 14 ...

In virtual experiments, AI repeatedly misread dead digital organisms as self-replicating life.

Artificial intelligence (AI) is rapidly becoming part of cosmetic dermatology, not as a replacement for dermatologists, but ...

Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help ...

Background Irritable bowel syndrome (IBS) is a complex disorder of gut-brain interaction, with heterogeneous symptoms, no ...

Extrachromosomal circular DNA has been identified as a novel component of stress granule cores, indicating its essential involvement in eukaryotic stress response pathways at the level of protein ...

BRAIN, an open-source AI scientist deploying three free computational tools to accelerate Alzheimer's drug discovery.